大数跨境

如何快速在高影响力英文期刊发表新冠肺炎论文

如何快速在高影响力英文期刊发表新冠肺炎论文 美捷登
2020-03-20
0
导读:为推进新型冠状病毒相关基础临床科研进展,

为推进新型冠状病毒相关基础临床科研进展,助力科研人员开展新型冠状病毒相关科学研究,发表与新型冠状病毒感染相关文章,共同抗击新型冠状肺炎疫情,美捷登特此分享为JAMA组稿和帮助科研人员投稿的信息与经验,带领大家快速在高影响力英文期刊上发表新冠肺炎论文!


投稿JAMA(详情链接:JAMA继续邀请美捷登组稿!及时分享临床与科研经验、共同抗击新冠病毒)


一、         准备英文Proposal (文末附Proposal模板供您参考)

1.     如果您已有英文版的Proposal, 直接投递到邮箱:medjadeneditor@gmail.com;

2.     如果您需要美捷登提供Proposal英文撰写等服务,请通过美捷登官网(http://www.medjaden.com/)进行系统投递,美捷登会及时与您联系,提供相应服务。


二、         提交英文Proposal

美捷登将作者投递过来或经美捷登服务后的Proposals依次编号整理,然后将正式提交给JAMA进行审阅。


三、         JAMA约稿回复通知

JAMA通常在1-4天内给予回复,并对感兴趣的Proposals提出问题、意见和建议。在收到JAMA的回复意见后,美捷登会第一时间通知作者。

1.     如果JAMA对您的Proposal感兴趣,建议您尝试按JAMA意见投稿JAMA,并在Cover Letter中进行相关说明(文末附Cover Letter模板供您参考)。

2.     如果JAMA未选中您的议题,建议您可以改投其他目标期刊。



投稿其他高影响力的目标期刊


您在将Proposal投JAMA的同时,亦可将Proposal投其他目标期刊。此外,如果您觉得您的议题不符合JAMA,可以将Proposal同时提交多份目标期刊(SCI期刊及IF查询官方网站https://mjl.clarivate.com/search-results)。向多份期刊提交Proposal不属一稿多投。在提交Proposal的同时,为节约时间建议您积极撰写文稿。如需美捷登的支持,可登陆美捷登官网(http://www.medjaden.com/)进行文稿评估和正式服务。在疫情期间,可享受“美捷登新冠专项研究基金”。


此外,华誉出版社(Xia & He Publishing Inc.)出版三份英文期刊,分别是Journal of Clinical and Translational Hepatology (已进入ESCI,今年有望进SCIE),Exploratory Research and Hypothesis in Medicine 和 Journal of Exploratory Research in Pharmacology。欢迎大家投稿。



在准备英文文稿过程中,美捷登愿意助大家一臂之力,帮助大家在抗击新冠肺炎疫情的同时及时有效地分享临床与科研经验、发表新冠论文!


附一

Proposal Template


XXXXX (Your name)

Affiliation/address: XXXXX

Telephone: XXXXX

E-mail: XXXXX


Dear Editor of JAMA,

I (We) wish to submit a scientific report (research/review article/case report) on the management of Coronavirus Disease 2019 (COVID-19)/SARS-CoV-2 infection (my experiences in living through the epidemic of COVID-19/my personal opinions on the management of the epidemic (select where appropriate).


XXXXXXXX (provide summary the article or your experiences or opinions) (100-200 words).

The tentative title of the article is “XXXX” and the structure is outlined below:

1. XXXX

2. XXXX

3. XXXX


I (We) believe the information provided in the article is useful for XXXXXXXX (brief description).


The estimated word number for the whole article is XXXXX, and the expected submission date is XX, 2020.


Enclosed below are/is XXXX for your references. (if necessary)


Sincerely yours,

XXXX (full name of the first/corresponding author)

XXXX (title)


附二

Cover Letter-Template for the authors of COVID-19 papers


Name: XXX

Affiliation/address: XXXXX

Telephone: XXXXX

E-mail: XXXXX


Dr. Edward H. Livingston

Deputy Editor of JAMA

Date (e.g. February 25, 2020)


Dear Professor Livingston,

We submitted you the proposal-MJDXXX on XXX (DATE) assisted by Selin He of Medjaden Bioscience Limited, and got a positive feedback. We are now submitting a manuscript entitled “XXXX”(Title) as XXX (research article, review article, case report or clinical study protocol, commentary, editorial, or viewpoint) after incorporating your comments (i.e. JAMA Comments/Questions listed if any).


We have reviewed all relevant publications on COVID-19 and taken actions in response to your comments. Our manuscript summarizes XXXX, and we believe that XXXX (describe the main content, structure or other opinions)


All authors have contributed to the study, and reviewed and approved the manuscript. We certify that this manuscript is not being considered for publication in part or in full elsewhere. The manuscript does not overlap with previous work. The authors report no conflicts of interest. In addition, Medjaden Bioscience Limited provided assistance in preparing the manuscript (only when this is true).


Thank you for considering this manuscript for publication.


Sincerely yours,

XXXX (full name of the first/corresponding author)

XXXX (your academic title, e.g. Professor/Associate professor)



如果您需要降低文稿重复率,或者有进一步的润色需求,您可以将您的文稿上传到美捷登投稿系统(电脑端):http://online.medjaden.com/control/login



往期精彩回顾


美捷登助力新冠研究,相关英文论文可享受免费标准编辑服务!


重磅!申请时间延长一个月,国自然科学基金委员会推迟2020年度项目申请与结题时间


访学|卡罗林斯卡学院2020年中国合作计划



长按二维码识别关注“美捷登”

【声明】内容源于网络
0
0
美捷登
1234
内容 1292
粉丝 0
美捷登 1234
总阅读0
粉丝0
内容1.3k